Match!
Nádia de Cássia Noronha
University of São Paulo
2Publications
1Citations
Publications 2
Newest
#1Nádia de Cássia Noronha (USP: University of São Paulo)
#2Amanda Mizukami (USP: University of São Paulo)H-Index: 6
Last.Kelen C. R. Malmegrim (USP: University of São Paulo)H-Index: 13
view all 8 authors...
The original article [1] contained an error in the presentation of the first author’s name, Nadia de Cassia Noronha. This has now been corrected.
#1Nádia de Cássia Noronha Nc (USP: University of São Paulo)
#2Nádia de Cássia Noronha (USP: University of São Paulo)
Last.Kelen C. R. Malmegrim (USP: University of São Paulo)H-Index: 13
view all 8 authors...
Multipotent mesenchymal stromal cells (MSC) have been widely explored for cell-based therapy of immune-mediated, inflammatory, and degenerative diseases, due to their immunosuppressive, immunomodulatory, and regenerative potentials. Preclinical studies and clinical trials have demonstrated promising therapeutic results although these have been somewhat limited. Aspects such as low in vivo MSC survival in inhospitable disease microenvironments, requirements for ex vivo cell overexpansion prior to...
1
Co-Authors